Playlist

Modern Maternal and Child Healthcare Center Opens Its Doors in Balkanabat

Today in 08:38

Source

In celebration of the National Healthcare and Pharmaceutical Industry Workers' Day, a state-of-the-art Maternal and Child Healthcare Center was officially inaugurated in the city of Balkanabat. The landmark event gathered regional and municipal officials, members of the Halk Maslahaty and Parliament, healthcare professionals, and community leaders. The opening ceremony featured festive cultural performances, musical numbers, and traditional Kushtdepdi dances.

The newly constructed medical complex consists of four- and five-story buildings designed to accommodate up to 305 patients. The center houses comprehensive maternity and postnatal wards, a gynecology division, pediatric units, and diagnostic consultation departments. The facility is equipped with advanced medical technology, including MRI, CT scanners, digital mammography, and fluorography units.

Notably, the center features the region's first 10-bed neonatal intensive care unit, fully outfitted with "Medicor" incubators from Hungary and high-precision German monitoring systems. These technologies allow medical staff to continuously monitor vital stats, body temperature, oxygen saturation, and respiratory functions of newborns.

During the ceremony, outstanding builders from the "Shadiyan Gurlushyk" enterprise were honored with gifts on behalf of the President of Turkmenistan, who also donated a new fleet of vehicles to support the medical center's operations.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌